http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1498705-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-00
filingDate 1975-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1978-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1498705-A
titleOfInvention 4-(alkoxy-phenyl)-2-pyrrolidones their preparation and us
abstract 1498705 4-(Alkoxyphenyl)-2-pyrrolidones, their preparation and use SCHERING AG 20 March 1975 [20 March 1974] 11686/75 Heading C2C Racemic and optically active 4-(alkoxyphenyl)-2-pyrrolidones of the formula wherein each R 1 and R 2 may be the same or different and is a hydrocarbon group which is optionally substituted by one or more halogen atoms, hydroxyl groups, cyano groups, carboxyl groups, alkoxy groups, alkoxycarbonyl, carboxamido or optionally substituted amino groups, or may be a heterocyclic group containing oxygen or sulphur, or one of R 1 and R 2 is hydrogen and the other represents said hydrocarbon group, or R 1 and R 2 together represent a C 1-3 alkylene group, with the proviso that when R 1 is methyl, R 3 is H or 5-methoxy, R 4 is H and X is oxygen, R 2 is other than methyl, R 3 represents a hydrogen atom or a methoxy group, R 4 represents a hydrogen atom or an alkyl, aryl, acyl or carboxamido group, and X represents an oxygen or sulphur atom, may be prepared (a) by hydrolysing and decarboxylating a compound of the formula in which R 1 <SP>1</SP> and R 2 <SP>1</SP> each represents a hydrogen atom or the corresponding group R 1 or R 2 , and R represents an alkyl group; (b) by subjecting a compound of the formula or an acid addition salt thereof, to ring closure with the elimination of the corresponding alcohol ROH; or (c) by subjecting a compound of the formula or an acid addition salt thereof, to ring closure with the elimination of water; the product of reaction (a), (b) or (c) optionally being (i) hydrocarbylated to convert -OR 1 <SP>1</SP> and/or -OR 2 <SP>1</SP> into -OR 1 and/or -OR 2 , (ii) alkylated, arylated or acylated at the -NH- group at position 1, (iii) converted to the corresponding thione, or (iv) subjected to racemic separation. In reaction (a) the hydrolysis reaction is preferably carried out with aqueous alkali in a water-miscible solvent at a temperature of 60-150‹ C.; the decarboxylation reaction may be carried out by heating the corresponding carboxylic acid at 160-280‹ C. in vacuo or in a high-boiling inert solvent. The ring closure of process (b) may be effected in an organic solvent at 50-150‹ C., and in the presence of a base when the starting material is a salt. The ring closure of reaction (c) may be effected by splitting off water at 160-280‹ C., preferably in vacuo, and in the presence of a tertiary base when the starting material is a salt. R 1 <SP>1</SP> or R 2 <SP>1</SP>, when hydrogen atoms, may be converted into alkyl groups by known methods, e.g. by heating with the corresponding halide or tosylate in a polar solvent in the presence of a base. Modification of the imino group in the 1-position may be carried out, for example, by heating at 40-150‹ C. in a polar solvent in the presence of a salt-former with an alkyl, aryl or acyl halide, or the reaction with a haloaryl may be carried out in the absence of a solvent but preferably in the presence of copper powder. The exchange of carbonyl oxygen for sulphur may be effected, for example, with a polysulphide in a solvent or in suspension in the presence of a base at 30-120‹ C. The 4-(substituted phenyl)-2- pyrrolidone-3-carboxylic ester starting material of Formula (II) may be obtained by reacting an appropriately substituted benzaldehyde with a malonic acid dialkyl ester, reacting the benzalmalonic diester product with nitromethane in the presence of trimethyl guanidine, followed by reduction of the resulting 1-(substituted phenyl)-2-nitroethyl-malonic acid dialkyl ester with hydrogen under pressure using a Raney Ni catalyst. The 3-(substituted phenyl)-4-aminobutyric acid alkyl ester starting materials of Formula (III) may be obtained by heating the benzal-malonic acid diester (prepared above) in aqueous alcohol at 60‹ C. with HCN in the presence of KCN, and hydrogenating the product under pressure in the presence of PtO 2 If the additive reaction with the HCN is effected under boiling conditions, the corresponding butyric acid starting material of the Formula (IV) is obtained. 3 - Isobutoxy - 4 - methoxy - benzaldehyde is prepared by boiling 3-hydroxy-4-methoxybenzaldehyde with KOH and isobutyl bromide in ethanol. (3 - Acetoxy - 4 - methoxy - benzal) - malonic acid diethyl ester is prepared by reacting (3- hydroxy - 4 - methoxy - benzal) - malonic acid diethyl ester with acetic anhydride in the presence of pyridine, whilst cooling with ice. The corresponding 4-acetoxy-3-methoxy compound is obtained in a similar manner. 4 - (3,4 - Dihydroxy - phenyl) - 2 - pyrrolidone is obtained by reacting the corresponding 3,4- dimethoxy compound at - 80‹ C. under anhydrous conditions in methylene chloride with boron tribromide. The compounds of formula are neuropsychotropic agents and may be formulated and applied in a conventional manner.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6075016-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6025361-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6153630-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5864037-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5939422-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5665737-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6268373-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6090816-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2123288-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6166041-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5591776-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5922751-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6310205-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6066641-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5744473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5889014-A
priorityDate 1974-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421888617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409908092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID95677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53865686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410994934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415797232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416147024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54271199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415845917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422068234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2414110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422392608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408497310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20346765

Total number of triples: 101.